Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A 96-Week, Phase IV, Randomized, Double-Blind, Multicenter Study of the Safety and Efficacy of EPZICOM Versus TRUVADA Administered in Combination with KALETRA in Antiretroviral-Naive HIV-1 Infected Subjects
abacavir
EPZ104057
NCT00244712
Infection, Human Immunodeficiency Virus I
Phase 4
 
January 2014

Powered by ideaPoint, Inc.